Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies.

Mitchell AJ.

J Neurol Neurosurg Psychiatry. 2009 Sep;80(9):966-75. doi: 10.1136/jnnp.2008.167791. Epub 2009 May 21. Review.

PMID:
19465413
3.

CSF biomarkers for mild cognitive impairment.

Blennow K.

J Intern Med. 2004 Sep;256(3):224-34. Review.

4.

CSF phosphorylated tau--does it constitute an accurate biological test for Alzheimer's disease?

Mitchell A, Brindle N.

Int J Geriatr Psychiatry. 2003 May;18(5):407-11. Review.

PMID:
12766916
5.

Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia: implications for trial design.

van Rossum IA, Vos S, Handels R, Visser PJ.

J Alzheimers Dis. 2010;20(3):881-91. doi: 10.3233/JAD-2010-091606. Review.

PMID:
20413876
6.

Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Levey A, Lah J, Goldstein F, Steenland K, Bliwise D.

Clin Ther. 2006 Jul;28(7):991-1001. Review.

PMID:
16990077
7.

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Ukoumunne O, Ladds EC, Martin S.

Cochrane Database Syst Rev. 2017 Mar 22;3:CD010803. doi: 10.1002/14651858.CD010803.pub2. Review.

PMID:
28328043
8.

CSF biomarkers for mild cognitive impairment and early Alzheimer's disease.

Andreasen N, Blennow K.

Clin Neurol Neurosurg. 2005 Apr;107(3):165-73. Review.

PMID:
15823670
9.

[Diagnosing the mild cognitive impairment stage of Alzheimer's disease].

Maruyama M, Matsui T, Tanji H, Ootsuki M, Nemoto M, Tomita N, Okamura N, Matsushita S, Higuchi S, Kodama M, Arai H, Sasaki H.

Seishin Shinkeigaku Zasshi. 2004;106(3):269-80. Review. Japanese.

PMID:
15164576
10.

[Alzheimer's disease as brain amyloidosis: diagnosis using cerebrospinal fluid abeta and tau].

Shoji M.

Rinsho Byori. 2006 May;54(5):503-8. Review. Japanese.

PMID:
16789421
11.

Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.

Formichi P, Battisti C, Radi E, Federico A.

J Cell Physiol. 2006 Jul;208(1):39-46. Review.

PMID:
16447254
12.

Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?

Mitchell AJ, Monge-Argilés JA, Sánchez-Paya J.

Pract Neurol. 2010 Aug;10(4):202-7. doi: 10.1136/jnnp.2010.217778. Review.

PMID:
20647526
13.
14.

Biological markers of Alzheimer's disease and mild cognitive impairment.

Maccioni RB, Lavados M, Maccioni CB, Mendoza-Naranjo A.

Curr Alzheimer Res. 2004 Nov;1(4):307-14. Review.

PMID:
15975059
15.

[Clinical heterogeneity in mild cognitive impairment--beyond clinical diagnosis--towards imaging amyloid].

Arai H.

Rinsho Shinkeigaku. 2004 Nov;44(11):924-8. Review. Japanese.

PMID:
15651333
16.

Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.

Small BJ, Gagnon E, Robinson B.

Geriatrics. 2007 Apr;62(4):19-23. Review.

PMID:
17408315
17.

Mild cognitive impairment as a diagnostic entity.

Petersen RC.

J Intern Med. 2004 Sep;256(3):183-94. Review.

18.

[MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods].

Förstl H, Werheid K, Ulm K, Schönknecht P, Schmidt R, Pantel J, Hörr R, Gutzmann H, Gertz HJ, Frölich L, Bickel H.

Dtsch Med Wochenschr. 2009 Jan;134(3):88-91. doi: 10.1055/s-0028-1105896. Epub 2009 Jan 13. Review. German.

PMID:
19142839
19.

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease.

Sobów T, Flirski M, Liberski PP.

Acta Neurobiol Exp (Wars). 2004;64(1):53-70. Review.

20.

Total and phosphorylated tau proteins: evaluation as core biomarker candidates in frontotemporal dementia.

Hampel H, Teipel SJ.

Dement Geriatr Cogn Disord. 2004;17(4):350-4. Review.

PMID:
15178952

Supplemental Content

Support Center